New Scoops

The Global Connected Drug Delivery Devices market size is expected to reach USD 717.7 million by 2025, according to a new report by Radiant Insights, Inc. The market is projected to expand at a strong CAGR of 25.1% during the forecast period. Factors contributing to the growth of this market include rise in awareness regarding adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. Based on the product type, connected drug delivery systems are categorized as sensors and integrated devices. Ask for free sample copy @  https://www.radiantinsights.com/research/connected-drug-delivery-devices-market/request-sample The sensors segment accounted for the largest market share of 72.6% in 2017. The connected sensors are cost-effective as compared to their integrated counterparts. Moreover, the cost of switching from a conventional systems to add-on sensors is low. The integrated systems are anticipated to witness the fastest ...

Factors such as growing number of contagious diseases, increasing expenditure for research and development can propel the market over the forecast period (2011 to 2022). In addition, increasing demand for generic drugs is also expected to boost the market growth. Download free request sample @  https://www.radiantinsights.com/research/global-penicillin-and-streptomycin-market-to-2022/request-sample Use of these antibiotics in the treatment of various bacterial infection is expected to boost the market. The penicillin drugs are being used in treatment of several diseases like meningitis, throat disease, among the others. streptomycin can be used in the treatment of Tuberculosis. Antibiotics can also offer benefits in highly complex medical procedures like organ transplantations. In addition, innovations and development of new products and use of these drugs in cell culture as ant-bacterial agent is expected to spur the market in the coming years. Furthermore, growing awareness...

Increase in funding by public and private bodies for conducting research on ocular disorders with the presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market. For instance, the recent approval of Zerviate (cetirizine) for the treatment of allergic conjunctivitis in 2017 and Humira (adalimumab) and Xiidra (lifitegrast) in 2016 as ophthalmic solutions for the treatment of uveitis and dry eyes are expected to boost the market growth. Get free request sample @  https://goo.gl/BrfQtK Numerous ongoing public-private partnership agreements in the pharmaceutical industry for the development of novel therapeutics are expected to provide this market with lucrative growth opportunities. In the recent years, a number of highly-effective and safe agents have emerged for the treatment of fungal ophthalmic diseases. Natamycin, amphotericin B, clotrimazole, are some of the most promising therapeutics present in the marke...

This report, with focus on top players in the global and Japan, studies the Orthopedic Braces and Supports market's development status and future trend in the global and Japan. It splits Orthopedic Braces and Supports market by type and by applications to fully and deeply research and reveal market profile and prospect. Get request sample brochure @  https://www.radiantinsights.com/research/2017-2022-global-and-japan-orthopedic-braces-and-supports-market-analysis-report/request-sample The major players includeDJO Finance LLC (US) Breg, Inc. (US) Ossur Hf (Iceland) DeRoyal Industries, Inc. (US) Bauerfeind AG (Germany) Otto Bock HealthCare (Germany) BSN Medical (Germany) medi GmbH & Co. KG (Germany) 3M Company (US) THUASNE Group (France) Shimmer (US) M BRACE RCA (US) JunoSports (US) FLA Orthopedics (US) Geographically, this report splits the Global market into the following regions: Asia Pacific Japan Tokyo Yokohama Osaka Nagoya...